Phase 4 N=197 Impact of Physician Directed Education on Patient Compliance With Hepatitis C Therapy
Chronic Hepatitis C · Genotype 1
Primary: Treatment Duration Compliance Rate — 85.4; 83.8 Percentage of compliance — p=0.4864
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=395 A Study to Evaluate Chronic Hepatitis C Infection in Treatment Experienced Adults
Chronic Hepatitis C Infection
Primary: Percentage of Participants With Sustained Virologic Response 12 Weeks After Treatment — 96.3 percentage of participants
Phase 2 N=78 Trial of Amrubicin as Treatment for Patients With HER2-Negative Metastatic Breast Cancer
Metastatic Breast Cancer
Primary: Progression-Free Survival (PFS) of MTD/Phase II Patients — 4.0 months
Phase 4 N=28 Raltegravir vs. Atazanavir in Combination With Truvada® for the Treatment of Antiretroviral naïve HIV Infected Patients
HIV Infections
Primary: Change From Baseline in CD4 Count at 48 Weeks — 192; 205 cells/uL
N/A N=114 Infant Aphakia Treatment Study (IATS)
Congenital Cataract
Primary: Visual Acuity — 0.80; 0.97 logMAR units — p=0.19
Phase 4 N=35 Does Allopurinol Prolong a Treated, Acute Gout Flare?
Gout
Primary: Resolution of the Acute Gout Attack — 15.4; 13.4 days — p=0.5
Phase 2 N=57 Lapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot Be Removed By Surgery
Adult Primary Hepatocellular Carcinoma · Advanced Adult Primary Liver Cancer · Localized Unresectable Adult Primary Liver Cancer
Primary: Response Rate — 0; 5 percentage of responding patients
Phase 4 N=50 Effectiveness of Oxymetazoline Added on Nasal Steroid in Rhinitis With Persistent Nasal Obstruction
Nasal Obstruction Present Finding
Primary: Effectiveness of Oxymetazoline in the Treatment of Rhinitis With Persistent Nasal Obstruction — 1.38; 1.67 units on a scale
Phase 4 N=30 Prophylaxis Versus on Demand Treatment for Children With Hemophilia A
Hemophilia A
Primary: Difference of Annualized Number of All Bleeds Between On-demand and Prophylaxis Period — 56.00 Bleeds
Phase 3 N=343 A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung
Non Squamous Lung Cancer
Primary: Progression-Free Survival (PFS) Based on IRR — 10.9; 7.0 months — p=<0.0001
Early Phase 1 N=40 Telemedicine in Cardiac Surgery: A Pilot Study
Coronary Artery Disease
Primary: Accuracy (FTF Decision on Patient Disposition vs. V-visit Decision on Patient Disposition) — 89 percentage of agreement
N/A N=24 Peer Visitation for OEF/OIF Veterans
Polytrauma · Blast Injuries
Primary: Post Traumatic Growth Inventory — 67.4 units on a scale
Phase 2 N=67 Lapatinib Versus Placebo Given Concurrently With Cisplatin And Radiotherapy In Patients With Unresected Head And Neck Cancer
Neoplasms, Head and Neck
Primary: Number of Participants (Par.) With Complete Response (CR), as Assessed by Independent Radiological Review — 12; 18 Participants — p=0.3658
Phase 3 N=667 A Study to Evaluate the Efficacy of Paliperidone Palmitate in the Prevention of Relapse of the Symptoms of Schizoaffective Disorder
Schizoaffective Disorder
Primary: Double-blind: Percentage of Participants Who Experienced Relapse — 15.2; 33.5; 11.5; 32.9 percentage of participants — p=<0.001
N/A N=51 Piloting an Internet-based Therapy for Insomnia in a Population of Veterans With Substance Use Disorders
Chronic Insomnia
Primary: Insomnia Severity Index (Total), Change From Baseline to Follow-up — 6.3 units on a scale